New problems for Mylan and Pfizer’s EpiPens

FDA last Friday announced that Mylan and Pfizer are still experiencing issues in supplying the North American market with EpiPens. The problems involve both EpiPens and its generic version, both developed and marketed by Mylan, but manufactured by its partner Pfizer. Importantly, however, the FDA has just detected that some labeling had been improperly placed on the injector. This is far different from the serious issues recently reported in St. Louis plant, where Pfizer produces EpiPens and to which FDA issued a warning letter in 2017.

(Source FDA)